
Entera Bio Investor Relations Material
Latest events

Q2 2025
8 Aug, 2025

Corporate Presentation
2 Jul, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Entera Bio Ltd
Access all reports
Entera Bio Ltd. is a biotechnology company focused on the development of oral drug formulations for conditions traditionally treated with injectable therapies. The company specializes in proprietary oral delivery technology to improve the bioavailability of large molecules, such as peptides and proteins. Entera Bio’s research targets metabolic and endocrine disorders, including osteoporosis and hypoparathyroidism. The company is headquartered in Jerusalem, Israel, and its shares are listed on the NASDAQ.
Key slides for Entera Bio Ltd


Corporate Presentation
Entera Bio Ltd


Corporate Presentation
Entera Bio Ltd
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
ENTX
Country
🇺🇸 United States